AI assistant
DEXCOM INC — Director's Dealing 2021
Aug 25, 2021
30198_dirs_2021-08-25_fc1dd6c4-f075-40f4-97c2-a5d30518a061.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2021-08-23
Reporting Person: Pacelli Steven Robert (Managing Dir., Dexcom Ventures)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-08-23 | Common Stock | S | 256 | $513.4095 | Disposed | 49907 | Direct |
| 2021-08-23 | Common Stock | S | 122 | $515.1392 | Disposed | 49785 | Direct |
| 2021-08-23 | Common Stock | S | 96 | $516.17 | Disposed | 49689 | Direct |
| 2021-08-23 | Common Stock | S | 604 | $517.9572 | Disposed | 49085 | Direct |
Footnotes
F1: On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan.
F2: This transaction was executed in multiple trades at prices ranging from $513.18 to $513.51. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F3: Included in this number are 16,171 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 4,996 of which were granted on March 8, 2019 and shall vest through March 8, 2022.
F4: This transaction was executed in multiple trades at prices ranging from $514.745 to $515.340. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F5: This transaction was executed in multiple trades at prices ranging from $517.54 to $517.96. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.